aspirin has been researched along with Stillbirth in 12 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Stillbirth: The event that a FETUS is born dead or stillborn.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of aspirin and heparin has improved the pregnancy outcome in obstetric APS and approximately 70% of pregnant women with APS have a successful pregnancy outcome." | 4.95 | Current insights in obstetric antiphospholipid syndrome. ( Radin, M; Schreiber, K; Sciascia, S, 2017) |
| " We sought to review the effect of aspirin, calcium supplementation, antihypertensive agents and magnesium sulphate on risk stillbirths." | 4.87 | Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. ( Bhutta, ZA; Imdad, A; Jabeen, M; Yakoob, MY, 2011) |
| "A retrospective study of 32 women with severe recurrent placenta-mediated complications (preeclampsia with severe features, placental abruption, severe intrauterine growth retardation or intra uterine fetal death) in spite of treatment with low molecular weight heparin and low dose aspirin in previous pregnancy." | 4.12 | Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study. ( Asher-Landsberg, J; Gamzu, R; Kliger, C; Kupferminc, MJ; Rimon, E; Skornick-Rapaport, A; Yogev, Y, 2022) |
| "Women with a prior pregnancy affected by FGR have a 20% to 30% risk of recurrence, but effective preventive strategies are lacking." | 2.72 | Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies. ( Blue, NR; Page, JM; Silver, RM, 2021) |
| "Stillbirth affects at least 2." | 2.58 | Care prior to and during subsequent pregnancies following stillbirth for improving outcomes. ( Ellwood, DA; Flenady, V; Heazell, AE; Lassi, ZS; Middleton, P; Murphy, MM; Shepherd, E; Silver, RM; Wilson, T; Wojcieszek, AM, 2018) |
| "Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies." | 1.46 | Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. ( Berghella, V; Bernabini, D; Dall'Asta, A; Eke, AC; Facchinetti, F; Ghi, T; Hoxha, A; Martinelli, P; Maruotti, GM; Monari, F; Rizzo, G; Rizzo, N; Roman, A; Ruffatti, A; Saccone, G; Sarno, L; Schuit, E; Simonazzi, G; Visentin, S; Xodo, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blue, NR | 1 |
| Page, JM | 1 |
| Silver, RM | 2 |
| Kupferminc, MJ | 1 |
| Kliger, C | 1 |
| Rimon, E | 1 |
| Asher-Landsberg, J | 1 |
| Skornick-Rapaport, A | 1 |
| Gamzu, R | 1 |
| Yogev, Y | 1 |
| Schreiber, K | 1 |
| Radin, M | 1 |
| Sciascia, S | 1 |
| Wojcieszek, AM | 1 |
| Shepherd, E | 1 |
| Middleton, P | 1 |
| Lassi, ZS | 1 |
| Wilson, T | 1 |
| Murphy, MM | 1 |
| Heazell, AE | 1 |
| Ellwood, DA | 1 |
| Flenady, V | 1 |
| Egan, AM | 1 |
| Brassill, MJ | 1 |
| Brosnan, E | 1 |
| Carmody, L | 1 |
| Clarke, H | 1 |
| Coogan Kelly, C | 1 |
| Culliney, L | 1 |
| Durkan, M | 1 |
| Fenlon, M | 1 |
| Ferry, P | 1 |
| Hanlon, G | 1 |
| Higgins, T | 1 |
| Hoashi, S | 1 |
| Khamis, A | 1 |
| Kinsley, B | 1 |
| Kinsley, T | 1 |
| Kirwan, B | 1 |
| Liew, A | 1 |
| McGurk, C | 1 |
| McHugh, C | 1 |
| Murphy, MS | 1 |
| Murphy, P | 1 |
| O'Halloran, D | 1 |
| O'Mahony, L | 1 |
| O'Sullivan, E | 1 |
| Nolan, M | 1 |
| Peter, M | 1 |
| Roberts, G | 1 |
| Smyth, A | 1 |
| Todd, M | 1 |
| Tuthill, A | 1 |
| Wan Mahmood, WA | 1 |
| Yousif, O | 1 |
| P Dunne, F | 1 |
| von Dadelszen, P | 1 |
| Magee, LA | 1 |
| Herrera, CA | 1 |
| Heuser, CC | 1 |
| Branch, DW | 1 |
| Saccone, G | 1 |
| Berghella, V | 1 |
| Maruotti, GM | 1 |
| Ghi, T | 1 |
| Rizzo, G | 1 |
| Simonazzi, G | 1 |
| Rizzo, N | 1 |
| Facchinetti, F | 1 |
| Dall'Asta, A | 1 |
| Visentin, S | 1 |
| Sarno, L | 1 |
| Xodo, S | 1 |
| Bernabini, D | 1 |
| Monari, F | 1 |
| Roman, A | 1 |
| Eke, AC | 1 |
| Hoxha, A | 1 |
| Ruffatti, A | 1 |
| Schuit, E | 1 |
| Martinelli, P | 1 |
| Buckingham, KL | 1 |
| Chamley, LW | 1 |
| Reddy, UM | 1 |
| Jabeen, M | 1 |
| Yakoob, MY | 1 |
| Imdad, A | 1 |
| Bhutta, ZA | 1 |
| Bonaminio, PN | 1 |
| de Regnier, R | 1 |
| Chang, E | 1 |
| Day, N | 1 |
| Manzi, S | 1 |
| Ramsey-Goldman, R | 1 |
6 reviews available for aspirin and Stillbirth
| Article | Year |
|---|---|
Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies.
Topics: Adult; Anticoagulants; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retardation; Gestational A | 2021 |
Current insights in obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2017 |
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.
Topics: Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Parent | 2018 |
Preventing deaths due to the hypertensive disorders of pregnancy.
Topics: Aspirin; Birth Intervals; Calcium; Cardiotocography; Dietary Supplements; Eclampsia; Female; Food Su | 2016 |
Management of pregnancy after stillbirth.
Topics: alpha-Fetoproteins; Aspirin; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Female; Fetal | 2010 |
Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths.
Topics: Antihypertensive Agents; Aspirin; Calcium; Dietary Supplements; Eclampsia; Female; Humans; Magnesium | 2011 |
6 other studies available for aspirin and Stillbirth
| Article | Year |
|---|---|
Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
Topics: Abruptio Placentae; Aspirin; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; Humans | 2022 |
An Irish National Diabetes in Pregnancy Audit: aiming for best outcomes for women with diabetes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Cesarean Section; Clinical Audit; Delivery of Health Care; De | 2020 |
Stillbirth: the impact of antiphospholipid syndrome?
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Infant, Newborn; Lupus Coagulation Inhi | 2017 |
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; beta 2-Glyc | 2017 |
A critical assessment of the role of antiphospholipid antibodies in infertility.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Aspirin; Clinical Trials as Topic; Drug T | 2009 |
Minor physical anomalies are not increased in the offspring of mothers with systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Congenital Abnormalities; Fe | 2006 |